The estimated Net Worth of Stefan Schreck is at least $893 Tausend dollars as of 14 August 2013. Stefan Schreck owns over 25,000 units of Endologix stock worth over $27,738 and over the last 21 years Stefan sold ELGX stock worth over $865,020.
Stefan has made over 3 trades of the Endologix stock since 2012, according to the Form 4 filled with the SEC. Most recently Stefan sold 25,000 units of ELGX stock worth $404,500 on 14 August 2013.
The largest trade Stefan's ever made was exercising 135,000 units of Endologix stock on 1 May 2012 worth over $589,950. On average, Stefan trades about 9,947 units every 25 days since 2004. As of 14 August 2013 Stefan still owns at least 126,080 units of Endologix stock.
You can see the complete history of Stefan Schreck stock trades at the bottom of the page.
Stefan's mailing address filed with the SEC is 2057 WHITE BIRCH DRIVE, , VISTA, CA, 92081.
Over the last 22 years, insiders at Endologix have traded over $72,068,611 worth of Endologix stock and bought 306,824 units worth $2,023,811 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott und Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of $13,088. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth $2,592.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
Endologix executives and other stock owners filed with the SEC include: